Brief: Sino Biopharmaceutical Says Acquisition Of 29.99% Equity Interest In Hob Biotech
30/10/2024 17:36
Oct 30 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* ACQUISITION OF 29.99% EQUITY INTEREST IN TARGET COMPANY
* DEAL FOR RMB630.0 MILLION
* UNIT ENTERED EQUITY TRANSFER AGREEMENT WITH HOB BIOTECH HK
* BEIJING RUNKANG AGREED TO ACQUIRE 29.99% STAKE IN HOB
BIOTECH
GROUP
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up